Brian G. Atwood - May 30, 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Director
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
Stock symbol
CERO
Transactions as of
May 30, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 05:02 PM
Previous filing
Apr 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ATWOOD BRIAN G Director CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO /s/ Andrew Kucharchuk, Attorney-in-Fact 2025-06-02 0001266567

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +123K $0.00 123K May 30, 2025 Common Stock 123K $0.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in equal monthly installments through May 30, 2027.

Remarks:

Exhibit 24 - Power of Attorney.